Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2025 14:16 ET | Source: Bragar Eagel & Squire

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Capricor allegedly misled investors about its DMD therapy’s FDA approval prospects; an FDA rejection letter citing lack of efficacy data sent shares down.
September 16, 2025 17:13 ET | Source: Bragar Eagel & Squire

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

The suit claims Capricor misled investors on its DMD drug deramiocel; FDA denied its BLA, citing lack of evidence, causing shares to fall.
September 14, 2025 09:44 ET | Source: The Rosen Law Firm PA

CAPR IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action – CAPR

NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October...
September 14, 2025 09:27 ET | Source: Bragar Eagel & Squire

CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Capricor Therapeutics, Inc. of the September 15th Deadline for the Class Action Lawsuit

Defendants allegedly misled investors on deramiocel’s FDA approval prospects; after a CRL denial, Capricor’s stock fell nearly 33%.
September 12, 2025 10:19 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased...
September 11, 2025 07:49 ET | Source: Bragar Eagel & Squire

CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Capricor Therapeutics, Inc. of the September 15th Deadline for the Class Action Lawsuit

The complaint alleges Capricor misled investors on deramiocel’s trial data and BLA prospects, concealing risks that led to FDA’s rejection.
September 08, 2025 10:06 ET | Source: Bernstein Liebhard LLP

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline
September 07, 2025 10:50 ET | Source: Bragar Eagel & Squire

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Capricor misled investors on deramiocel’s approval prospects; FDA rejected its BLA, citing lack of efficacy data, causing shares to fall 33%.
September 07, 2025 08:55 ET | Source: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or...
September 05, 2025 19:30 ET | Source: The Rosen Law Firm PA

CAPR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 15 Deadline in Securities Class Action – CAPR

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October...